CANbridge: Janny Wang
CANbridge Life Sciences has appointed a new director of quality assurance, Janny Wang.
Beijing, China-headquartered CANbridge Life Sciences is a clinical-stage biopharmaceutical company focused on developing and eventually commercialising western drug candidates in China, South Korea and Taiwan.
Prior to joining CANbridge, Wang held positions at Teva Pharmaceuticals and Bayer Pharmaceuticals subsidiary, Dihon Pharmaceutical Group.
Wang studied chemical analysis at Zhejiang University of Technology.
